Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety.
暂无分享,去创建一个
K. Totpal | J. Fox | L. Deforge | J. Bussiere | S. Kelley | L. Harris | D. Xie | David Xie | Louise A. Harris | Jeanine L. Bussiere